Literature DB >> 1537827

The proteinase: mucus proteinase inhibitor binding stoichiometry.

C Boudier1, J G Bieth.   

Abstract

In the nanomolar enzyme and inhibitor concentration range, 1 mol of mucus proteinase inhibitor (MPI) inhibits 1 mol of neutrophil elastase, cathepsin G, trypsin, and chymotrypsin. In the micromolar concentration range, the enzyme:inhibitor binding stoichiometry is still 1:1 for elastase but shifts to 2:1 for the three other proteinases. These data could be confirmed by three nonenzymatic methods: (i) fluorescence anisotropy measurements of mixtures of proteinases with 5-dimethylaminonaphthalene-1-sulfonylated or fluoresceinylated MPI, (ii) absorption spectrocospy of fluorescein-MPI-proteinase complexes isolated by gel filtration, (iii) analytical ultracentrifugation which showed that the molecular mass of the MPI-chymotrypsin complex is 56 kDa, whereas that of the MPI-elastase complex is 39 kDa. The binary MPI-elastase complex is unable to inhibit trypsin or cathepsin G. On the other hand, 1 mol of elastase displaces 2 mol of trypsin or cathepsin G from their ternary complexes with MPI.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1537827

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Characterization of the ovine ortholog of secretory leukoprotease inhibitor.

Authors:  Thomas I Brown; Rohit Mistry; Robert Gray; Margaret Imrie; David D Collie; Jean-Michel Sallenave
Journal:  Mamm Genome       Date:  2005-09-14       Impact factor: 2.957

2.  A novel locust (Schistocerca gregaria) serine protease inhibitor with a high affinity for neutrophil elastase.

Authors:  Michèle Brillard-Bourdet; Ahmed Hamdaoui; Eric Hajjar; Christian Boudier; Nathalie Reuter; Laurence Ehret-Sabatier; Joseph G Bieth; Francis Gauthier
Journal:  Biochem J       Date:  2006-12-15       Impact factor: 3.857

3.  Inhibition by recombinant SLPI and half-SLPI (Asn55-Ala107) of elastase and cathepsin G activities: consequence for neutrophil-platelet cooperation.

Authors:  P Renesto; V Balloy; T Kamimura; K Masuda; A Imaizumi; M Chignard
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

4.  Oxidized mucus proteinase inhibitor: a fairly potent neutrophil elastase inhibitor.

Authors:  C Boudier; J G Bieth
Journal:  Biochem J       Date:  1994-10-01       Impact factor: 3.857

5.  Protease inhibitors derived from elafin and SLPI and engineered to have enhanced specificity towards neutrophil serine proteases.

Authors:  Marie-Louise Zani; Kévin Baranger; Nicolas Guyot; Sandrine Dallet-Choisy; Thierry Moreau
Journal:  Protein Sci       Date:  2009-03       Impact factor: 6.725

Review 6.  The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease.

Authors:  J M Sallenave
Journal:  Respir Res       Date:  2000-08-23

Review 7.  Inhibitors of Serine Proteases in Regulating the Production and Function of Neutrophil Extracellular Traps.

Authors:  Pawel Majewski; Monika Majchrzak-Gorecka; Beata Grygier; Joanna Skrzeczynska-Moncznik; Oktawia Osiecka; Joanna Cichy
Journal:  Front Immunol       Date:  2016-06-30       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.